Abstract
The identification of structural retinal layer differences between patients diagnosed with certain psychiatric disorders and healthy controls has provided a potentially promising route to the identification of biomarkers for these disorders. Optical coherence tomography has been used to study whether retinal structural differences exist in schizophrenia spectrum disorders (SSD), bipolar disorder (BPD), major depressive disorder (MDD), obsessive-compulsive disorder (OCD), attention deficit hyperactivity disorder (ADHD), and alcohol and opiate use disorders. However, there is considerable variation in the amount of available evidence relating to each disorder and heterogeneity in the results obtained. We conducted the first systematic review and meta-analysis of evidence across all psychiatric disorders for which data was available. The quality of the evidence was graded and key confounding variables were accounted for. Of 381 screened articles, 87 were included. The evidence was of very low to moderate quality. Meta-analyses revealed that compared to healthy controls, the peripapillary retinal nerve fiber layer (pRNFL) was significantly thinner in SSD (SMD = -0.32; p<0.001), BPD (SMD = -0.4; p<0.001), OCD (SMD = -0.26; p=0.041), and ADHD (SMD = -0.48; p=0.033). Macular thickness was only significantly less in SSD (SMD = -0.59; p<0.001). pRNFL quadrant analyses revealed that reduced pRNFL thickness in SSD and BPD was most prominent in the superior and inferior quadrants. Macular subfield analyses indicated that BPD may have region-specific effects on retinal thickness. In conclusion, these findings suggest substantial retinal differences in SSD and BPD, reinforcing their potential as biomarkers in clinical settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a Young Talents in Clinical Research grant of the Swiss Academy of Medical Sciences (SAMS) and the G. & J. Bangerter-Rhyner Foundation (Grant no. YTCR-19/22, to NK); and by an ERC Synergy Grant (Grant no. 101118756, to PH).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
https://pubmed.ncbi.nlm.nih.gov/ https://www.embase.com https://www.apa.org/pubs/databases
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
